Evidence map›Paper›PMID 31937726›Full record

Observational studyIndian journal of ophthalmology2020

Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus.

Umesh C Behera, Harsha Bhattacharjee, Taraprasad Das, Clare Gilbert, G V S Murthy, R Rajalakshmi, Hira B Pant, SPEED study group

Open access · diamondAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Research Progress of Diabetes-related Glaucoma: Mechanisms, Impacts and Management Strategies.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Umesh C BeheraRetina Vitreous Service, L V Prasad Eye Institute, Bhubaneswar, Odisha, India.
Harsha BhattacharjeeRetina Vitreous Service, Sri Sankaradeva Nethralaya, Guwahati, Assam, India.
Taraprasad DasRetina Vitreous Service, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Clare GilbertDepartment of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
G V S MurthyDepartment of Clinical Research, Indian School of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
R RajalakshmiDepartment of Ophthalmology, Dr Mohan's Diabetes Foundation, Chennai, Tamil Nadu, India.
Hira B PantDepartment of Clinical Research, Indian School of Public Health, Public Health Foundation of India, Hyderabad, Telangana, India.
SPEED study group
L V Prasad Eye Institute · INPublic Health Foundation of India · INSankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To estimate the proportion of people with type 2 diabetes mellitus (T2DM) and glaucoma in a facility-based cross-sectional observational study in India. Methods: All people received a comprehensive eye examination. Glaucoma-specific examinations included applanation tonometry, optic disc and cup evaluation, and stereo biomicroscopy in all people; gonioscopy and visual field testing in glaucoma suspects. The International Society of Geographic and Epidemiologic Ophthalmology guidelines were used to diagnose and classify glaucoma. Results: The study recruited 11,182 people (average age: 58.2 ± 10.6; range 39-96 years). Glaucoma was diagnosed in 4.9% (n = 547) people. About 76.8% (n = 420) of those with glaucoma had bilateral disease, and 98.7% (n = 540) were >40 years. Among people with bilateral disease, 94.5% (n = 397) had primary glaucoma - open angle in 59.3% (n = 228) and angle closure in 40.2% (n = 169). Diabetes duration was ≤10 years in 71.5% (n = 300) people. On linear regression, the following were associated with glaucoma: advancing age [compared with < 40 years age group; odds ratio [OR] in 50-60 year age group: 1.36 [95% confidence interval (CI): 1.01-1.8], P < 0.035); >60 years age group (OR: 2.05, 95% CI: 1.57-2.67; P < 0.001), and diabetic neuropathy (OR: 2.62, 95% CI: 1.35-5.10, P < 0.003). Glycemic control did not have significant association (P = 0.425). Conclusion: Presence of glaucoma in people with T2DM in this cohort was similar to the general population prevalence studies in India. Glaucoma was invariably bilateral. A comprehensive eye examination in people age 40 years and older with diabetes and/or glaucoma is beneficial.

Indexed as

Rural PopulationUrban PopulationAdultAgedAged, 80 and overAge DistributionCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic RetinopathyFemaleFollow-Up StudiesGlaucomaHospitalsHumansIncidenceIndiaDiabetesdiabetic retinopathyglaucoma

Identifiers

PMID31937726
PMCPMC7001170
OpenAlexW2999950201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.